Journal
PROSTAGLANDINS & OTHER LIPID MEDIATORS
Volume 80, Issue 3-4, Pages 136-143Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2006.06.001
Keywords
15-deoxy-12,14-prostaglandin J2; retinal pigment epithelial cells; inflammation; interferon gamma; MHC class II; PPAR gamma
Categories
Ask authors/readers for more resources
Retinal pigment epithelial (RPE) cells constitute the external part of the blood-retinal-barrier and play a pivotal role in the regulation of retinal immunity. In the present work, we investigated the effects of 15-deoxy-12,14-prostaglandin J2 (15 PGJ2), an endogenous ligand of PPAR gamma, on the IFN gamma-induced expression of MHC class II on RPE cells. Indeed, pathological expression of MHC class II molecules at the surface of RPE cells is a common feature of many blinding conditions. We demonstrated that 15 PGJ2 inhibited the IFN gamma-mediated induction of MHC class II on RPE cells without affecting the level of MHC class I and CD54 expression. The other PPAR gamma agonist rosiglitazone or troglitazone had no similar effects. Moreover, the inhibitory effect of 15 PGJ2 was not abrogated by co-incubation with PPAR gamma antagonists and did not involve the modulation of STAT-1, AKT or ERK1/2 phosphorylation, nor CIITA, IRF1 or IRF2 transcription. In conclusion, 15 PGJ2 inhibits strongly and specifically the IFN gamma-induced MHC class II expression on RPE cells by a PPAR gamma independent mechanism. Given the differential role of MHC classes I and II in the development of autoimmune uveitis and the potential toxicity of 15 PGJ2, our data's suggest that the development of novel small molecules targeting similar PPAR gamma independent pathways would be useful for the future management of uveitis. (c) 2006 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available